Jason Neale

503 total citations
26 papers, 389 citations indexed

About

Jason Neale is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Jason Neale has authored 26 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Jason Neale's work include Carcinogens and Genotoxicity Assessment (9 papers), Inflammatory mediators and NSAID effects (4 papers) and Synthesis and Biological Evaluation (4 papers). Jason Neale is often cited by papers focused on Carcinogens and Genotoxicity Assessment (9 papers), Inflammatory mediators and NSAID effects (4 papers) and Synthesis and Biological Evaluation (4 papers). Jason Neale collaborates with scholars based in United States, United Kingdom and Switzerland. Jason Neale's co-authors include David W. Hein, Mark A. Doll, William M. Pierce, J. Christopher States, Brian J. Dean, Ned B. Smith, Shuang Zhao, Julia H. Cochran, Jian Cai and W. Glenn McGregor and has published in prestigious journals such as Blood, The Journal of Immunology and Cancer Research.

In The Last Decade

Jason Neale

25 papers receiving 386 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jason Neale United States 13 209 116 115 46 31 26 389
Nona Rama United Kingdom 12 255 1.2× 81 0.7× 108 0.9× 42 0.9× 15 0.5× 17 534
Andrea L. Merz United States 11 195 0.9× 62 0.5× 115 1.0× 16 0.3× 47 1.5× 14 381
A. Maillet Singapore 7 275 1.3× 54 0.5× 116 1.0× 51 1.1× 40 1.3× 9 508
Chunhong Wang China 14 167 0.8× 106 0.9× 78 0.7× 23 0.5× 28 0.9× 40 438
Ram Kumar Singh India 10 401 1.9× 78 0.7× 163 1.4× 24 0.5× 24 0.8× 15 586
Caterina Bartolacci Italy 11 224 1.1× 77 0.7× 78 0.7× 29 0.6× 20 0.6× 15 345
Mutsa Madondo Australia 9 211 1.0× 61 0.5× 220 1.9× 17 0.4× 25 0.8× 11 686
Catherine Henderson United Kingdom 10 318 1.5× 87 0.8× 150 1.3× 24 0.5× 21 0.7× 17 531
Chengbo Wang China 11 212 1.0× 119 1.0× 94 0.8× 13 0.3× 37 1.2× 30 424
Xiaoli Liao China 13 238 1.1× 120 1.0× 110 1.0× 15 0.3× 25 0.8× 29 426

Countries citing papers authored by Jason Neale

Since Specialization
Citations

This map shows the geographic impact of Jason Neale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason Neale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason Neale more than expected).

Fields of papers citing papers by Jason Neale

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason Neale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason Neale. The network helps show where Jason Neale may publish in the future.

Co-authorship network of co-authors of Jason Neale

This figure shows the co-authorship network connecting the top 25 collaborators of Jason Neale. A scholar is included among the top collaborators of Jason Neale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason Neale. Jason Neale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kollert, Florian, Jason Neale, Nicolas Frances, et al.. (2024). AB1034 CHARACTERIZATION OF RO7507062, A CD19-TARGETING T-CELL BISPECIFIC ANTIBODY (CD19TCB), AND DESIGN OF A PHASE 1 TRIAL IN SYSTEMIC LUPUS ERYTHEMATOSUS. Annals of the Rheumatic Diseases. 83. 1837–1838.
2.
DiPersio, John F., Steven M. Devine, Jonathan Hoggatt, et al.. (2020). Phase 1 Clinical Study of Mgta-145 in Combination with Plerixafor Shows Rapid Single-Day Mobilization and Collection of CD34+ HSCs without G-CSF. Biology of Blood and Marrow Transplantation. 26(3). S55–S55. 1 indexed citations
3.
Pearse, Bradley R., Jennifer Proctor, Sean M. McDonough, et al.. (2020). A Non-Genotoxic Anti-CD117 Antibody Drug Conjugate (ADC) Designed for Patient Conditioning Prior to Stem Cell Transplant and HSC-Based Gene Therapy Has a Broad Therapeutic Window across Species. Biology of Blood and Marrow Transplantation. 26(3). S35–S36. 1 indexed citations
4.
Li, Fu, Michelle Ulrich, Vincent Feng-Sheng Shih, et al.. (2019). Mouse Strains Influence Clearance and Efficacy of Antibody and Antibody–Drug Conjugate Via Fc–FcγR Interaction. Molecular Cancer Therapeutics. 18(4). 780–787. 37 indexed citations
5.
Neumann, Christopher S., Martha E. Anderson, Julia H. Cochran, et al.. (2018). Targeted Delivery of Cytotoxic NAMPT Inhibitors Using Antibody–Drug Conjugates. Molecular Cancer Therapeutics. 17(12). 2633–2642. 32 indexed citations
6.
Epps, Heather A. Van, Ryan A. Heiser, Anthony Cao, et al.. (2016). Denintuzumab Mafodotin Stimulates Immune Responses and Synergizes with CD20 Antibodies to Heighten Anti-Tumor Activity in Preclinical Models of Non-Hodgkin Lymphoma. Blood. 128(22). 4177–4177. 2 indexed citations
7.
Cook, Adam, George Doherty, Kevin J. Hunt, et al.. (2009). Identification and characterization of a potent and selective antagonist of the prostaglandin D2 receptor (94.23). The Journal of Immunology. 182(Supplement_1). 94.23–94.23. 1 indexed citations
9.
Neale, Jason, Mark A. Doll, J. Christopher States, et al.. (2009). Effect of rapid human N-acetyltransferase 2 haplotype on DNA damage and mutagenesis induced by 2-amino-3-methylimidazo-[4,5-f]quinoline (IQ) and 2-amino-3,8-dimethylimidazo-[4,5-f]quinoxaline (MeIQx). Mutation research. Fundamental and molecular mechanisms of mutagenesis. 684(1-2). 66–73. 16 indexed citations
10.
Neale, Jason, K. Grant Taylor, Leonard C. Waite, et al.. (2009). ChemInform Abstract: Bone Selective Effect of an Estradiol Conjugate with a Novel Tetracycline‐Derived Bone‐Targeting Agent.. ChemInform. 40(25). 1 indexed citations
11.
Doll, Mark A., J. Christopher States, Ned B. Smith, et al.. (2009). Role of human CYP1A1 and NAT2 in 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced mutagenicity and DNA adducts. Xenobiotica. 39(5). 399–406. 13 indexed citations
12.
Neale, Jason, K. Grant Taylor, Leonard C. Waite, et al.. (2008). Bone selective effect of an estradiol conjugate with a novel tetracycline-derived bone-targeting agent. Bioorganic & Medicinal Chemistry Letters. 19(3). 680–683. 58 indexed citations
13.
Neale, Jason, Ned B. Smith, William M. Pierce, & David W. Hein. (2008). METHODS FOR AROMATIC AND HETEROCYCLIC AMINE CARCINOGEN-DNA ADDUCT ANALYSIS BY LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY. Polycyclic aromatic compounds. 28(4-5). 402–417. 12 indexed citations
14.
Hein, David W., et al.. (2008). Systemic Functional Expression of N-Acetyltransferase Polymorphism in the F344 Nat2 Congenic Rat. Drug Metabolism and Disposition. 36(12). 2452–2459. 14 indexed citations
16.
Ravoori, Srivani, Yi Feng, Jason Neale, et al.. (2007). Dose-dependent reduction of 3,2′-dimethyl-4-aminobiphenyl-derived DNA adducts in colon and liver of rats administered celecoxib. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 638(1-2). 103–109. 8 indexed citations
18.
Feng, Yi, Jason Neale, Mark A. Doll, & David W. Hein. (2006). The protective effect of celecoxib, a cyclooxygenase-2 inhibitor, on aberrant crypt formation in rats administered 3,2’-dimethyl-4-aminobiphenyl. Cancer Research. 66. 746–746. 1 indexed citations
19.
Wakefield, Larissa, et al.. (2006). N-Acetyltransferase (Nat) 1 and 2 Expression in Nat2 Knockout Mice. Journal of Pharmacology and Experimental Therapeutics. 319(2). 724–728. 20 indexed citations
20.
Barker, David F., Anwar Husain, Jason Neale, et al.. (2006). Functional properties of an alternative, tissue-specific promoter for human arylamine N-acetyltransferase 1. Pharmacogenetics and Genomics. 16(7). 515–525. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026